Skip to main content
Top
Published in: Digestive Diseases and Sciences 1/2019

01-01-2019 | Editorial

Whipple’s Disease: A Well-Done Outcome to a Rare Disease

Authors: Joesph Sellin, Ian L. P. Beales

Published in: Digestive Diseases and Sciences | Issue 1/2019

Login to get access

Excerpt

Whipple’s disease (WD) is a condition of which all gastroenterologists likely learn about in medical school, occasionally investigate for, and very rarely see. Despite this rarity, or maybe because of it, there has been a longstanding fascination with the disease. In 1907, Dr. George Hoyt Whipple described a case of arthritis, weight loss, and diarrhea, which when examined postmortem was remarkable for prominent periodic acid-Schiff (PAS)-staining foamy macrophages in the small intestinal lamina propria. He hypothesized that there was an underlying disorder of fat metabolism and termed, what would eventually be known as Whipple’s disease, intestinal lipodystrophy. The first small bowel biopsy diagnosis of Whipple’s was made in 1958; since then, the causative organism has been identified and cultured, its genome sequenced, and new polymerase chain reaction (PCR)-based bacterial identification and immunohistochemical diagnostic tests developed. …
Literature
1.
go back to reference Dobbins W. Whipple’s Disease. Springfield, IL: Charles C Thomas Pub Ltd; 1987. Dobbins W. Whipple’s Disease. Springfield, IL: Charles C Thomas Pub Ltd; 1987.
2.
go back to reference Keita AK, Mediannikov O, Ratmanov P, et al. Looking for Tropheryma whipplei source and reservoir in rural Senegal. Am J Trop Med Hyg. 2013;88:339–343.CrossRef Keita AK, Mediannikov O, Ratmanov P, et al. Looking for Tropheryma whipplei source and reservoir in rural Senegal. Am J Trop Med Hyg. 2013;88:339–343.CrossRef
3.
go back to reference Keita AK, Dubot-Peres A, Phommasone K, et al. High prevalence of Tropheryma whipplei in Lao kindergarten children. PLoS Negl Trop Dis. 2015;9:e0003538.CrossRef Keita AK, Dubot-Peres A, Phommasone K, et al. High prevalence of Tropheryma whipplei in Lao kindergarten children. PLoS Negl Trop Dis. 2015;9:e0003538.CrossRef
4.
go back to reference Biagi F, Balduzzi D, Delvino P, Schiepatti A, Klersy C, Corazza GR. Prevalence of Whipple’s disease in north-western Italy. Eur J Clin Microbiol Infect Dis. 2015;34:1347–1348.CrossRef Biagi F, Balduzzi D, Delvino P, Schiepatti A, Klersy C, Corazza GR. Prevalence of Whipple’s disease in north-western Italy. Eur J Clin Microbiol Infect Dis. 2015;34:1347–1348.CrossRef
6.
go back to reference Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine. 2010;89:337–345.CrossRef Lagier JC, Lepidi H, Raoult D, Fenollar F. Systemic Tropheryma whipplei: clinical presentation of 142 patients with infections diagnosed or confirmed in a reference center. Medicine. 2010;89:337–345.CrossRef
7.
go back to reference Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical Whipple disease: clinical, endoscopic, and histopathologic features in 191 patients. Medicine. 2015;94:e714.CrossRef Gunther U, Moos V, Offenmuller G, et al. Gastrointestinal diagnosis of classical Whipple disease: clinical, endoscopic, and histopathologic features in 191 patients. Medicine. 2015;94:e714.CrossRef
8.
go back to reference Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.CrossRef Lagier JC, Fenollar F, Lepidi H, Giorgi R, Million M, Raoult D. Treatment of classic Whipple’s disease: from in vitro results to clinical outcome. J Antimicrob Chemother. 2014;69:219–227.CrossRef
9.
go back to reference Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. (quiz 411–472).CrossRef Feurle GE, Junga NS, Marth T. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple’s disease. Gastroenterology. 2010;138:478–486. (quiz 411–472).CrossRef
10.
go back to reference Feurle GE, Moos V, Blaker H, et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple’s disease. J Infect. 2013;66:263–270.CrossRef Feurle GE, Moos V, Blaker H, et al. Intravenous ceftriaxone, followed by 12 or three months of oral treatment with trimethoprim-sulfamethoxazole in Whipple’s disease. J Infect. 2013;66:263–270.CrossRef
11.
go back to reference Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.CrossRef Fenollar F, Perreal C, Raoult D. Tropheryma whipplei natural resistance to trimethoprim and sulphonamides in vitro. Int J Antimicrob Agents. 2014;43:388–390.CrossRef
12.
go back to reference Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.CrossRef Fenollar F, Lagier JC, Raoult D. Tropheryma whipplei and Whipple’s disease. J Infect. 2014;69:103–112.CrossRef
13.
go back to reference Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.CrossRef Boulos A, Rolain JM, Raoult D. Antibiotic susceptibility of Tropheryma whipplei in MRC5 cells. Antimicrob Agents Chemother. 2004;48:747–752.CrossRef
14.
go back to reference Biagi F, Biagi GL, Corazza GR. What is the best therapy for Whipple’s disease? Our point of view. Scand J Gastroenterol. 2017;52:465–466.CrossRef Biagi F, Biagi GL, Corazza GR. What is the best therapy for Whipple’s disease? Our point of view. Scand J Gastroenterol. 2017;52:465–466.CrossRef
15.
go back to reference Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.CrossRef Ramzan NN, Loftus E Jr, Burgart LJ, et al. Diagnosis and monitoring of Whipple disease by polymerase chain reaction. Ann Intern Med. 1997;126:520–527.CrossRef
16.
go back to reference Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A. Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl Environ Microbiol. 1998;64:760–762.PubMedPubMedCentral Maiwald M, Schuhmacher F, Ditton HJ, von Herbay A. Environmental occurrence of the Whipple’s disease bacterium (Tropheryma whippelii). Appl Environ Microbiol. 1998;64:760–762.PubMedPubMedCentral
Metadata
Title
Whipple’s Disease: A Well-Done Outcome to a Rare Disease
Authors
Joesph Sellin
Ian L. P. Beales
Publication date
01-01-2019
Publisher
Springer US
Published in
Digestive Diseases and Sciences / Issue 1/2019
Print ISSN: 0163-2116
Electronic ISSN: 1573-2568
DOI
https://doi.org/10.1007/s10620-018-5342-7

Other articles of this Issue 1/2019

Digestive Diseases and Sciences 1/2019 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.